We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
References
1
This presentation is based on a larger book project I am undertaking with Tom McGarity entitled “Bending Science” (forthcoming Harvard U. Press 2008).Google Scholar
2
See, e.g., Blumenstyke, Goldie, The Price of Research: A Berkeley Scientists Says a Corporate Sponsor Tried to Bury his Unwelcome Findings and Then Buy his Silence, THE CHRONICLE, Oct. 31, 2003.Google Scholar
3
Renner, Rebecca, Conflict Brewing over Herbicide's Link to Frog Deformities, 298 SCIENCE 938 (2002).CrossRefGoogle ScholarPubMed
In re Silica Prods. Liab Litig., 398 F. Supp. 2d 563 (S.D. Tex. 2005).Google Scholar
6
Bekelman, Justin E.Li, Yan & Gross, Cary P., Scope and Impact of Financial Conflicts of Interest in Biomedical Research, 289 JAMA 454 (2003).CrossRefGoogle ScholarPubMed
Needleman, Herbert L., Salem Comes to the National Institute of Health: Notes From Inside the Crucible of Scientific Integrity, 90 PEDIATRICS 977 (1992).Google Scholar
9
Fischer, Paul M., Science and Subpoenas: When Do the Courts Become Instruments of Manipulation? 59 Law & Contemporary Problems 159, 159 (1996).CrossRefGoogle Scholar
10
Kennedy, Donald, Prologue, in Steinzor, Rena & Wagner, Wendy, eds., Rescuing Science from Politics vi (Wagner, Wendy & Steinzor, Rena, eds. 2006).CrossRefGoogle Scholar
11
Daubert v. Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993).Google Scholar
12
Siharath v. Sandoz Pharmaceuticals. Corp., 131 F. Supp. 2d 1347 (N.D. Ga. 2001), aff'd sub nom. Rider v. Sandoz Pharmaceuticals. Corp., 295 F.3d 1194 (11th Cir. 2002).Google Scholar